{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:39:00Z","timestamp":1785901140975,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006823","name":"Boston Children&apos;s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jpedsurg.2022.01.062","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T11:09:49Z","timestamp":1644836989000},"page":"999-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic stem cell therapy"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-3162","authenticated-orcid":false,"given":"Daniel F.","family":"Labuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlyn E.","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Kycia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-0125","authenticated-orcid":false,"given":"Dario O.","family":"Fauza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jpedsurg.2022.01.062_bib0001","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/scd.2020.0012","article-title":"Hematogenous donor cell routing pathway after transamniotic stem cell therapy","volume":"29","author":"Tracy","year":"2020","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpedsurg.2020.02.041","article-title":"Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy in a healthy model","author":"Tracy","year":"2020","journal-title":"J Pediatr Surg"},{"issue":"1\u20132","key":"10.1016\/j.jpedsurg.2022.01.062_bib0003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/pr.2017.228","article-title":"Transamniotic stem cell therapy: a novel strategy for the prenatal management of congenital anomalies","volume":"83","author":"Fauza","year":"2018","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-60761-999-4_7","article-title":"Amniotic and placental mesenchymal stem cell isolation and culture","volume":"698","author":"Klein","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.jpedsurg.2022.01.062_bib0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jpedsurg.2022.01.062_bib0006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/onc.2015.160","article-title":"Plexin-B1 signalling promotes androgen receptor translocation to the nucleus","volume":"35","author":"Williamson","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jpedsurg.2022.01.062_bib0007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.jpedsurg.2022.01.062_bib0008","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13287-018-1039-2","article-title":"Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization","volume":"9","author":"Philipp","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jpedsurg.2022.01.062_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(80)90384-1","article-title":"Induction of severe intrauterine growth retardation in the Sprague-Dawley rat","volume":"137","author":"Van Geijn","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0010","article-title":"Spermidine Prevents Heart Injury in Neonatal Rats Exposed to Intrauterine Hypoxia by Inhibiting Oxidative Stress and Mitochondrial Fragmentation","volume":"2019","author":"Chai","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.jpedsurg.2022.01.062_bib0011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpedsurg.2014.10.004","article-title":"Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells","volume":"50","author":"Dionigi","year":"2015","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0012","first-page":"1","article-title":"Initial mechanistic screening of transamniotic stem cell therapy in the rodent model of spina bifida: host bone marrow and paracrine activity","author":"Lazow","year":"2020","journal-title":"Fetal Diagn Ther"},{"issue":"Pt 14","key":"10.1016\/j.jpedsurg.2022.01.062_bib0013","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1113\/jphysiol.2009.173013","article-title":"Placental efficiency and adaptation: endocrine regulation","volume":"587","author":"Fowden","year":"2009","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2022.01.062_bib0014","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41598-020-79664-6","article-title":"Interferon-gamma enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis","volume":"11","author":"Kanai","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jpedsurg.2022.01.062_bib0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.placenta.2015.03.003","article-title":"Animal models of fetal growth restriction: considerations for translational medicine","volume":"36","author":"Swanson","year":"2015","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.jpedsurg.2022.01.062_bib0016","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1515\/jpm-2019-0116","article-title":"Placenta previa and the risk of intrauterine growth restriction (IUGR): a systematic review and meta-analysis","volume":"47","author":"Balayla","year":"2019","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0017","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fendo.2019.00055","article-title":"Neonatal morbidities of fetal growth restriction: pathophysiology and impact","volume":"10","author":"Malhotra","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.placenta.2015.11.006","article-title":"Telomere homeostasis in IUGR placentas - a review","volume":"39","author":"Biron-Shental","year":"2016","journal-title":"Placenta"},{"issue":"23","key":"10.1016\/j.jpedsurg.2022.01.062_bib0019","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1042\/CS20171118","article-title":"Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure","volume":"131","author":"Elfarra","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.jpedsurg.2022.01.062_bib0020","doi-asserted-by":"crossref","first-page":"e13386","DOI":"10.1111\/aji.13386","article-title":"Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats","volume":"85","author":"Travis","year":"2021","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.jpedsurg.2022.01.062_bib0021","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"issue":"39","key":"10.1016\/j.jpedsurg.2022.01.062_bib0022","doi-asserted-by":"crossref","first-page":"16295","DOI":"10.1073\/pnas.1109478108","article-title":"Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions","volume":"108","author":"Chakraborty","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jpedsurg.2022.01.062_bib0023","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jcb.22091","article-title":"Trafficking and differentiation of mesenchymal stem cells","volume":"106","author":"Liu","year":"2009","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.jpedsurg.2022.01.062_bib0024","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.1909","article-title":"A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells","volume":"15","author":"Hong","year":"2009","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.jpedsurg.2022.01.062_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/plac.1999.0441","article-title":"Studies of mesenchymal cells from 1st trimester human placenta: expression of cytokeratin outside the trophoblast lineage","volume":"20","author":"Haigh","year":"1999","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.jpedsurg.2022.01.062_bib0026","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bpobgyn.2004.07.001","article-title":"Amniotic fluid and placental stem cells","volume":"18","author":"Fauza","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.jpedsurg.2022.01.062_bib0027","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/6.5.485","article-title":"Villous sprouting: fundamental mechanisms of human placental development","volume":"6","author":"Castellucci","year":"2000","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jpedsurg.2022.01.062_bib0028","first-page":"57","article-title":"Tissue interactions in the control of trophoblast invasion","volume":"55","author":"Aplin","year":"2000","journal-title":"J Reprod Fertil Suppl"},{"issue":"2\u20134","key":"10.1016\/j.jpedsurg.2022.01.062_bib0029","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1387\/ijdb.140083ms","article-title":"Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy","volume":"58","author":"Soares","year":"2014","journal-title":"Int J Dev Biol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2022.01.062_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1293\/tox.2018-0042","article-title":"Morphology and physiology of rat placenta for toxicological evaluation","volume":"32","author":"Furukawa","year":"2019","journal-title":"J Toxicol Pathol"},{"issue":"18","key":"10.1016\/j.jpedsurg.2022.01.062_bib0031","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1089\/scd.2014.0581","article-title":"Licensing by Inflammatory Cytokines Abolishes Heterogeneity of Immunosuppressive Function of Mesenchymal Stem Cell Population","volume":"24","author":"Szabo","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"11","key":"10.1016\/j.jpedsurg.2022.01.062_bib0032","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/bloodadvances.2017006205","article-title":"Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNgamma priming","volume":"1","author":"Chinnadurai","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jpedsurg.2022.01.062_bib0033","first-page":"1","article-title":"IFNGamma priming protects fetal and embryonic MSC from NK cell-mediated killing and improves their immunosuppressive properties: role of activating and inhibitory receptors","volume":"05","author":"Giuliani","year":"2014","journal-title":"J Cell Sci Ther"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346822001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346822001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:43:51Z","timestamp":1758357831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346822001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0022346822001415"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.01.062","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic stem cell therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2022.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}